See more : Taiwan Mobile Co., Ltd. (3045.TW) Income Statement Analysis – Financial Results
Complete financial analysis of PetVivo Holdings, Inc. (PETV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PetVivo Holdings, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- PRO DV AG (PDA.DE) Income Statement Analysis – Financial Results
- Deliveroo plc (DROOF) Income Statement Analysis – Financial Results
- Sinic Holdings (Group) Company Limited (2103.HK) Income Statement Analysis – Financial Results
- Blockchain Venture Capital Inc. (BVCI.CN) Income Statement Analysis – Financial Results
- LiveCare, Inc. (LVCE) Income Statement Analysis – Financial Results
PetVivo Holdings, Inc. (PETV)
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 968.71K | 917.16K | 115.59K | 12.58K | 3.59K | 77.94K | 1.51K | 7.12K | 75.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 229.18K | 526.82K | 201.15K | 10.70K | 19.71K | 77.94K | 643.39K | 746.85K | 743.63K | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 739.53K | 390.35K | -85.57K | 1.88K | -16.12K | 0.00 | -641.88K | -739.72K | -668.63K | -1.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 76.34% | 42.56% | -74.03% | 14.97% | -449.33% | 0.00% | -42,508.48% | -10,383.51% | -891.51% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.27M | 690.58K | 474.88K | 98.23K | 12.67K | 200.98K | 118.94K | 167.89K | 168.60K | 4.40K | 119.30K | 0.00 | 0.00 | 157.30K |
| General & Administrative | 6.69M | 5.02M | 3.15M | 1.77M | 1.23M | 3.60M | 2.17M | 16.23M | 3.16M | 1.20M | 36.85M | 82.40K | 102.40K | 103.68K |
| Selling & Marketing | 3.40M | 3.41M | 1.35M | 94.98K | 171.51K | 38.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.80K |
| SG&A | 10.09M | 8.43M | 4.50M | 1.86M | 1.40M | 3.64M | 2.17M | 16.23M | 3.16M | 1.20M | 36.85M | 82.40K | 102.40K | 105.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 559.54K | 646.92K | 2.17M | 16.23M | 3.16M | 0.00 | 24.44M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 11.36M | 9.12M | 4.97M | 1.96M | 1.97M | 4.49M | 2.29M | 16.40M | 3.33M | 1.20M | 36.97M | 82.40K | 102.40K | 262.78K |
| Cost & Expenses | 11.59M | 9.65M | 5.17M | 1.97M | 1.99M | 4.57M | 2.29M | 16.40M | 3.33M | 1.20M | 36.97M | 82.40K | 102.40K | 262.78K |
| Interest Income | 0.00 | 15.84K | 9.85K | 228.60K | 32.19K | 84.95K | 0.00 | 0.00 | 0.00 | 0.00 | 19.53K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 228.60K | 32.19K | 84.95K | 74.02K | 188.51K | 270.58K | 399.16K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 126.85K | 114.43K | 65.15K | 86.71K | 559.54K | 646.92K | 643.39K | 746.85K | 743.63K | 10.48K | 36.97M | 3.81K | 227.00 | 659.00 |
| EBITDA | -10.49M | -8.62M | -4.99M | -1.87M | -1.49M | -3.92M | -1.64M | -16.39M | -2.51M | -1.20M | -19.68K | -78.59K | -102.18K | -262.12K |
| EBITDA Ratio | -1,083.35% | -952.23% | -4,345.73% | -14,885.32% | -39,724.53% | -5,032.45% | -108,737.02% | -219,579.00% | -3,343.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -10.62M | -8.73M | -5.06M | -1.96M | -2.02M | -4.67M | -2.29M | -16.39M | -3.25M | -1.20M | -36.97M | -82.40K | -102.40K | -262.78K |
| Operating Income Ratio | -1,096.45% | -952.23% | -4,374.69% | -15,574.72% | -56,190.97% | -5,995.70% | -151,345.50% | -230,062.51% | -4,334.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -333.96K | 15.84K | 41.53K | -1.56M | -66.60K | -84.95K | -52.02K | -132.05K | -1.48M | -363.84K | -19.68K | -3.81K | -227.00 | -659.00 |
| Income Before Tax | -10.96M | -8.72M | -5.01M | -3.52M | -2.08M | -4.76M | -2.34M | -16.52M | -4.73M | -1.57M | -36.99M | -86.21K | -102.63K | -263.44K |
| Income Before Tax Ratio | -1,130.92% | -950.50% | -4,338.76% | -28,007.47% | -58,047.21% | -6,104.70% | -154,790.60% | -231,916.03% | -6,307.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -15.84K | -73.21K | 228.60K | 32.19K | 84.95K | 74.02K | -990.17K | -1.08M | 388.68K | -19.68K | 0.00 | 0.00 | 0.00 |
| Net Income | -10.96M | -8.70M | -4.94M | -3.75M | -2.11M | -4.76M | -2.34M | -15.53M | -3.65M | -1.57M | -36.99M | -86.21K | -102.63K | -263.44K |
| Net Income Ratio | -1,130.92% | -948.77% | -4,275.42% | -29,824.89% | -58,944.23% | -6,104.70% | -154,790.60% | -218,017.03% | -4,868.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.78 | -0.85 | -0.56 | -0.61 | -0.10 | -1.03 | -0.61 | -7.71 | -2.07 | -0.91 | -308.77 | -1.55 | -2.00 | -5.86 |
| EPS Diluted | -0.78 | -0.85 | -0.56 | -0.61 | -0.10 | -1.03 | -0.61 | -7.71 | -2.07 | -0.91 | -308.77 | -1.55 | -2.00 | -5.86 |
| Weighted Avg Shares Out | 13.97M | 10.22M | 8.76M | 6.20M | 21.22M | 4.61M | 3.81M | 2.01M | 1.77M | 1.71M | 119.81K | 55.69K | 51.37K | 44.98K |
| Weighted Avg Shares Out (Dil) | 13.97M | 10.22M | 8.76M | 6.20M | 21.22M | 4.61M | 3.81M | 2.01M | 1.77M | 1.71M | 119.81K | 55.69K | 51.37K | 44.98K |
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021
MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, February 10, 2022...
Trending Penny Stocks to Buy For Under $4? Check These 3 Out
These penny stocks are trending right now, are they worth buying? The post Trending Penny Stocks to Buy For Under $4?
Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch
Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now?
Penny Stocks To Buy For A Short Squeeze? 5 To Watch Now
Short squeeze penny stocks to watch right now. The post Penny Stocks To Buy For A Short Squeeze?
5 Penny Stocks To Buy Now According To Insiders In November 2021
Hot penny stocks insiders are buying in November The post 5 Penny Stocks To Buy Now According To Insiders In November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PetVivo Holdings, Inc. (PETV) CEO John Lai on Q2 2022 Results - Earnings Call Transcript
PetVivo Holdings, Inc. (PETV) CEO John Lai on Q2 2022 Results - Earnings Call Transcript
PETVIVO HOLDINGS, INC. TO ANNOUNCE SECOND QUARTER 2022 RESULTS
MINNEAPOLIS, MN, US, Nov. 11, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will release financial results for the second fiscal year quarter 2022 on...
3 Hot Penny Stocks That Retail Traders Are Watching Right Now
Why retail traders are watching these penny stocks right now The post 3 Hot Penny Stocks That Retail Traders Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Hot Penny Stocks You Need to Know About in November
Check these penny stocks out for your November watchlist The post Hot Penny Stocks You Need to Know About in November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Are These Penny Stocks on Your List? If Not, Here's Why They Should
Which penny stocks are on your October watchlist? The post Are These Penny Stocks on Your List?
Source: https://incomestatements.info
Category: Stock Reports